Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 277Neoplasms 202Prostatic Neoplasms 118Polycystic Ovary Syndrome 114Colorectal Neoplasms 104Carcinoma, Hepatocellular 103Carcinoma, Non-Small-Cell Lung 88Lung Neoplasms 70Stomach Neoplasms 62Precursor Cell Lymphoblastic Leukemia-Lymphoma 60Pain 59Neoplasm Metastasis 54Multiple Myeloma 52Pancreatic Neoplasms 46Keratosis, Actinic 46Pain, Postoperative 43Head and Neck Neoplasms 43Leukemia, Myeloid, Acute 40Leiomyoma 39Recurrence 38Liver Neoplasms 38Colonic Neoplasms 37Uterine Cervical Neoplasms 35Lymphoma 35Brain Neoplasms 34Infertility 33Papillomavirus Infections 32Ovarian Neoplasms 31Lymphoma, Follicular 31Lymphoma, Non-Hodgkin 30

Interventions

Sirolimus 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Kasabach-Merritt Syndrome × Clear all
NCT04448873 2023-09-26

Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma

Children's Hospital of Fudan University

Phase 4 Completed
30 enrolled

Kaposiform Hemangioendothelioma, Kasabach-Merritt Syndrome

NCT04077515 2023-01-30

Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma

Children's Hospital of Fudan University

Phase 4 Completed
92 enrolled

Kaposiform Hemangioendothelioma, Hemangioma, Kasabach-Merritt Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡